-

INVESTIGATION REMINDER: Scott+Scott Attorneys at Law LLP Investigates DuPont de Nemours, Inc.’s Directors and Officers for Breach of Fiduciary Duties – DD

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continuing investigation whether certain directors and officers of DuPont de Nemours, Inc. (“DuPont”) (NYSE: DD) breached their fiduciary duties to DuPont and its shareholders. If you are a DuPont shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether members of DuPont’s board of directors or senior management failed to manage DuPont in an acceptable manner, in breach of their fiduciary duties to DuPont, and whether DuPont and its shareholders have suffered damages as a result.

On June 2, 2023, DuPont announced that it had agreed to pay $1.185 billion with The Chemours Company and Corteva, Inc., to settle a class action lawsuit relating to PFAS-related drinking water claims of a class of public water systems. DuPont’s share of the settlement is about $400 million.

What You Can Do

If you are a DuPont shareholder, you may have legal claims against DuPont’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at 844-818-6982, or jpettigrew@scott-scott.com.

About Scott+Scott

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300
San Diego, CA 92101
844-818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NYSE:DD

Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300
San Diego, CA 92101
844-818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Picard Medical Inc. (NASDAQ: PMI)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Picard Medical Inc., Patrick NJ Schnegelsberg, Matt Schuster, Yuncai “Richard” Fang, Chris Hsieh, Westpark Capital, Inc., Sentinel Brokers Company, Inc., R.F. Lafferty & Co. Inc., American Trust Investments, and MaloneBailey, LLP (collectively, the “Defendants”). The action, w...

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Navan, Inc. (NASDAQ: NAVN)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Navan, Inc. (“Navan” or the “Company”) (NASDAQ: NAVN) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Navan is a corporate travel and...

UBIQUITI INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Ubiquiti Inc.’s Directors and Officers for Breach of Fiduciary Duties – UI

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Ubiquiti Inc. (“Ubiquiti”) (NYSE: UI) breached their fiduciary duties to Ubiquiti and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether members of Ubiquiti’s board of directors or senior management failed to manage Ubiquiti in an acceptable manner, in breach of their fiduciary duties...
Back to Newsroom